Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: A review

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Abstract

Tuberculosis (TB)-associated uveitis is a common cause of infectious uveitis in the developing world. Diagnosis of TB uveitis remains a challenge. The role of interferon gamma release assays (IGRAs) is uncertain. Herein we summarise the available literature on the utility of IGRAs in the diagnosis and management of TB uveitis. We searched PubMed database from 1 August 2010 to 31 July 2020 using the following keywords alone and in combination: â € interferon-gamma release assay', â € QuantiFERON', â € T-SPOT.TB', â € TB uveitis', â € serpiginous like choroiditis', â € tuberculoma', â € TB vasculitis', â € TB panuveitis' and â € ocular tuberculosis'. Data from 58 relevant studies were collated. The review is focused on currently marketed versions of IGRA tests: QuantiFERON-TB Gold In-Tube assay, QuantiFERON-TB Gold Plus assay (QFT-Plus) and T-SPOT.TB. We found limited evidence regarding the diagnostic utility of IGRA in patients with uveitis. No study was identified evaluating the newer QFT test-the QFT-Plus-in patients with uveitis. Similarly, there is lack of data directly comparing QFT-Plus with T-SPOT.TB specifically for the diagnosis of TB uveitis.

Original languageEnglish
Article numbere000663
JournalBMJ Open Ophthalmology
Volume6
Issue number1
DOIs
Publication statusPublished - 12 May 2021

Keywords

  • diagnostic tests/investigation
  • infection
  • inflammation

Fingerprint

Dive into the research topics of 'Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: A review'. Together they form a unique fingerprint.

Cite this